531015
VENMAX
Start SIP
Invest Now
Start SIP in VENMAX
Performance
- Low
- ₹25
- High
- ₹30
- 52 Week Low
- ₹18
- 52 Week High
- ₹37
- Open Price₹28
- Previous Close₹28
- Volume435
- 50 DMA₹26.33
- 100 DMA₹26.45
- 200 DMA₹25.14
Investment Returns
- Over 1 Month + 5.79%
- Over 3 Month -2.51%
- Over 6 Month -4.11%
- Over 1 Year -1.86%
Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!
Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.8
- PEG Ratio
- 0.1
- Market Cap Cr
- 15
- P/B Ratio
- 2.5
- Average True Range
- 2.74
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.25
- RSI
- 57.84
- MFI
- 39.19
Venmax Drugs & Pharmaceuticals Financials
Venmax Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹27.97
+
0.38
(1.38%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹26.06
- 50 Day
- ₹26.33
- 100 Day
- ₹26.45
- 200 Day
- ₹25.14
Resistance and Support
27.49
- R3 35.72
- R2 32.94
- R1 30.27
- S1 24.82
- S2 22.04
- S3 19.37
Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-07 | Quarterly Results | |
| 2025-11-12 | Quarterly Results | |
| 2025-09-02 | Amalgamation & A.G.M. | |
| 2025-08-16 | Others | Inter alia, to consider and approve 1. Allotment of Equity Shares pursuant to conversion of Convertible Equity Share Warrants. |
| 2025-07-23 | Quarterly Results |
Venmax Drugs & Pharmaceuticals F&O
About Venmax Drugs & Pharmaceuticals
- NSE Symbol
- VENMAX
- BSE Symbol
- 531015
- ISIN
- INE154G01022
Similar Stocks to Venmax Drugs & Pharmaceuticals
Venmax Drugs & Pharmaceuticals FAQs
Venmax Drugs & Pharmaceuticals share price is ₹27 As on 11 February, 2026 | 16:30
The Market Cap of Venmax Drugs & Pharmaceuticals is ₹14.7 Cr As on 11 February, 2026 | 16:30
The P/E ratio of Venmax Drugs & Pharmaceuticals is 16.8 As on 11 February, 2026 | 16:30
The PB ratio of Venmax Drugs & Pharmaceuticals is 2.5 As on 11 February, 2026 | 16:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.